CC1qR/CR and gC1qR/p33: Observations in cancer

Molecular Immunology

Volumn 61, Issue 2, 2014, Pages 100-109

  Peerschke, Ellinor I B ^a   Ghebrehiwet, Berhane ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

C1q receptors; C1qR and cancer; Cancer, cC1qR and gC1qR

Indexed keywords

CALRETICULIN; COMPLEMENT COMPONENT C RECEPTOR; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1Q RECEPTOR; COMPLEMENT RECEPTOR; PROTEIN P33; UNCLASSIFIED DRUG;

ANGIOGENESIS; CANCER CELL; CANCER CELL DESTRUCTION; CELL PROLIFERATION; CELL SURVIVAL; HUMAN; IMMUNE EVASION; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; TUMOR MICROENVIRONMENT;

C1Q RECEPTORS; C1QR AND CANCER; CANCER, CC1QR AND GC1QR;

ANIMALS; CALRETICULIN; CARRIER PROTEINS; COMPLEMENT C1Q; HUMANS; MITOCHONDRIAL PROTEINS; NEOPLASMS;

EID: 84907598273     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.06.011     Document Type: Review

References (71)

1. Agostinis C., Bulla R., Tripodo C., Gismondi A., Stabile H., Bossi F., Guarnotta C., Garlanda C., De Seta F., Spessotto P., Santoni A., Ghebrehiwet B., Girardi G., Tedesco F. An alternative role of C1q in cell migration and tissue remodelling: contribution to trophoblast invasion and placental development. J. Immunol. 2010, 185:4420-4429.
2. Arlaud G.J., Gaboriaud C., Thielens N.M., Rossi V., Bersch B., Hernandez J.-F., Fontecilla-Camps J.C. Structural biology of C1: dissection of a complex molecular machinery. Immunol. Rev. 2001, 180:136-145.
3. Barclay A.N. Signal regulatory protein alpha (SIRP-α)/CD47 interaction and function. Curr. Opin. Immunol. 2009, 21:47-52.
4. Bossi F., Tripodo C., Rizzi L., Bulla R., Agostinis C., Guarnotta C., Munaut C., Baldassarre G., Papa G., Zorzet S., Ghebrehiwet B., Ling G.S., Botto M., Tedesco F. C1q as a unique player in angiogenesis with therapeutic implication in wound healing. Proc Natl Acad Sci U S A 2014, 111:4209-4214.
5. Brodsky-Doyle B., Leonhard K.R., Reid K.B.M. Circular-dichroism and electron microscopy studies of human subcomponent C1q before and after limited proteolysis by pepsin. Biochem. J. 1976, 159:279.
6. Budayova-Spano M., Lacroix M., Thielens N.M., Arlaud G.J., Fontecilla-Camps J.C., Gaboriaud C. The crystal structure of the zymogen catalytic domain of complement protease C1r reveals that a disruptive mechanical stress is required to trigger activation of the C1 complex. EMBO J. 2002, 21:231-239.
7. Caine G.J., Stonelake P.S., Lip G.Y.H., Kehoe S.T. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasis 2002, 4:465-473.
8. Calcott M.A., Muller-Eberhard H.J. C1q protein of human complement. Biochemistry 1972, 11:3443-3450.
9. Chao M.P., Jaiswal S., Weissman-Tsukamoto R., Alizadeh A.A., Gentles A.J., Volkmer J., Weiskopf K., Willingham S.B., Raveh T., Park C.Y., Majeti R., Weissman I.L. Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47. Sci. Transl. Med. 2010, 2:63-94.
10. Chen A., Gaddipati S., Volkman D.J., Peerschke E.I.B., Ghebrehiwet B. Human T cells possess specific receptors for C1q: role in activation and proliferation. J. Immunol. 1994, 153:1430-1440.
11. Cooper N.R. The classical complement pathway: activation and regulation of the first complement component. Adv. Immunol. 1985, 37:151-216.
12. Dembitzer F.R., Kinoshita Y., Burstein D., Phelps R.G., Beasley M.B., Garcia R., Harpaz N., Jaffer S., Thung S.N., Unger P.D., Ghebrehiwet B., Peerschke E.I. gC1qR expression in normal and pathologic human tissues: differential expression in tissues of epithelial and mesenchymal origin. J. Histochem. Cytochem. 2012, 60:467-474.
13. Dickler H.B., Kunkel H.G. Interaction of aggregated gamma-globulin with B lymphocyte. J. Exp. Med. 1972, 136:191-196.
14. Feng X., Tonneesen M.G., Peerschke E.I., Ghebrehiwet B. Cooperation of C1q receptors and integrins in C1q-mediated endothelial cell spreading. J. Immunol. 2002, 168:2441-2448.
15. Fliegel L., Burns K., MacLennan D.H., Reitheimer R.A.F., Michalak M. Molecular cloning of the high affinity calcium-binding protein (calreticulin) of skeletal muscle sarcoplasmic reticulum. J. Biol. Chem. 1989, 264:2152-2158.
16. Fogal V., Zhang L., Krajewski S., Ruoslahti E. Mitochondrial/cell-surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma. Cancer Res. 2008, 68:7210-7218.
17. Gaboriaud C., Païdassi H., Frachet P., Tacnet-Delorme P., Thielens N.M., Arlaud G.J. C1q: a versatile pattern recognition molecule and sensor of altered self. Collagen-related Lectins in Innate Immunity 2007, vol. 81:1-15. Research Signpost.
18. Gaboriaud C., Juanhuix J., Gruez A., Lacroix M., Darnault C., Pignol D., Verger D., Fontecilla-Camps J.C., Arlaud G. The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties. J. Biol. Chem. 2009, 278:46974-46982.
19. Ghebrehiwet B., Hamburger M. Purification of and partial characterization of a C1q inhibitor from the membrane of human peripheral lymphocytes. J. Immunol. 1982, 129:157-162.
20. Ghebrehiwet B., Silvestri L., McDevitt C. Identification of the Raji cell membrane-derived C1q inhibitor as a receptor for human C1q. Purification and immunochemical characterization. J. Exp. Med. 1984, 160:1375-1389.
21. Ghebrehiwet B., Habicht G.S., Beck G. Interaction of C1q with its receptor on cultured cell lines induces an anti-proliferative response. Clin. Immunol. Immunopathol. 1990, 54:148-160.
22. Ghebrehiwet B., Lim B.L., Peerschke E.I.B., Willis A.C., Reid K.B.M. Isolation cDNA cloning, and overexpression of a 33-kDa cell surface glycoprotein that binds to the globular 'heads' of C1q. J. Exp. Med. 1994, 179:1809-1821.
23. Ghebrehiwet B., Lim B.-L., Kumar R., Feng X., Peerschke E.I.B. gC1q-R/p33, a member of a new class of multifunctional and multicompartmental cellular proteins, is involved in inflammation and infection. Immunol. Rev. 2001, 180:65-77.
24. Ghebrehiwet B., Jesty J., Peerschke E.I.B. gC1qR/p33: structure-function predictions from the crystal structure. Immunobiology 2002, 205:421-432.
25. Ghebrehiwet B., Feng X., Kumar R., Peerschke E.I.B. Complement component C1q induces endothelial cell adhesion and spreading through a docking/signaling partnership of C1q receptors and intergrins. Int. Immunopharmacol. 2003, 3:299-310.
26. Ghebrehiwet B., Peerschke E.I.B. cC1q-R (calreticulin) and gC1q-R/p33: ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection. Mol. Immunol. 2004, 41:173-183.
27. Ghebrehiwet B., Ji Y., Valentino A., Pednekar L., Ramadass M., Habiel D., Kew R.R., Hosszu K.H., Galanakis D.K., Kishore U., Peerschke E.I.B. Soluble gC1qR is an autocrine signal that induces B1R expression on endothelial cells. J. Immunol. 2014, 192:377-384.
28. Ghebrehiwet B., Jesty J., Vinayagasundaram U., Vinayagasundaram R., Ji Y., Valentino A., Tumma N., Hosszu K.K., Peerschke E.I. Targeting gC1qR domains for therapy against infection and inflammation. Adv. Exp. Med. Biol. 2013, 735:97-110.
29. Guo N., Weremowicz S., Lynch N., Schwaeble W., Lim B.L., Morton C.C., Peerschke E.I.B., Reid K.B.M., Ghebrehiwet B., Sastry K.N. Assignment of C1QBP encoding the C1q globular domain binding protein (gC1q-R) to human chromosome 17 band p13.3 by in situ hybridization. Cytogenet. Cell Genet. 1997, 77:283-284.
30. Henson P.M. A role for calreticulin in the clearance of apoptotic cells and in the innate immune system. Calreticulin 2003, 151-161. Kluwer Academic/Plenum Publishers, New York, NY, USA. 2nd ed. P. Eggleton, M. Michalek (Eds.).
31. Hong Q., Sze C.-I., Lin S.-R., Lee M.-H., He R.-Y., Schultz L., Chang J.-Y., Chen S.-J., Boackle R.J., Hsu L.-J., Chang N.-S. Complement C1q activates tumor suppressor WWOX to induce apoptosis in prostate cancer cells. PLoS ONE 2009, 4(6):e5755. 10.1371/journal.pone.0005755.
32. Hosszu K.K., Valentino A., Vinayagasundaram U., Vinayagasundaram R., Joyce M.G., Ji Y., Peerschke E.I., Ghebrehiwet B. DC-SIGN, C1q and gC1qR form a tri-molecular receptor complex on the surface of monocyte-derived immature dendritic cells. Blood 2012, 120:1228-1236.
33. Jiang J., Zhang Y., Krainer A., Xu R.-M. Crystal structure of p32, a doughnut-shaped acidic mitochondrial matrix protein. Proc. Natl. Acad. Sci. U S A 1999, 96:3572-3577.
34. Joseph K., Ghebrehiwet B., Peerschke E.I.B., Reid K.B.M., Kaplan A.P. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor which binds to the globular heads of C1q (gC1q-R). Proc. Natl. Acad. Sci. U S A 1996, 93:8552-8557.
35. Johnson S.J., Hakansson K.O. Biochemical and molecular properties of calreticulin. Calreticulin 2003, 9-18. Kluwer Academic/Plenum Publishers, New York, NY, USA. 2nd ed. P. Eggleton, M. Michalek (Eds.).
36. Kaplan A.P. Mechanisms of bradykinin formation. Urticaria and Angioedema 2004, 51-72. Marcel Dekker Inc., NY. M.W. Greaves, A.P. Kaplan (Eds.).
37. Kim K-B., Yi J-S., Nguyen N., Lee J-H., Kwon Y-C., Ahn B-Y., Cho H., Kim Y.K., Yoo H-J., Lee J-S., Ko Y-G. Cell-surface receptor for complement component C1q (gC1qR) is a key regulator for lamellipodia formation and cancer metastasis. J. Biol. Chem. 2001, 286:23093-23101.
38. Kishore U., Reid K.B.M. Modular organization of proteins containing C1q-like globular domain. Immunopharmacology 1999, 42:15-21.
39. Kishore U., Reid K.B.M. C1q: structure, function and receptors. Immunopharmacology 2000, 49:159-170.
40. Kishore U., Kojouharova M.S., Reid K.B.M. Recent progress in the understanding of the structure-function relationships of the globular head region of C1q. Immunobiology 2002, 205:355-364.
41. Knobel H.R., Villiger W., Isliker H. Chemical analysis and electron microscopy studies of human C1q prepared by different methods. Eur. J. Immunol. 1975, 5:78-82.
42. Malhotra R., Reid K.B.M. Studies on the isolation of human C1q receptor. Biochem. Soc. Trans. 1988, 16:735-736.
43. Malhotra R., Thiel S., Reid K.B.M., Sim R.B. Human leukocyte C1q receptor binds other soluble proteins with collagen domains. J. Exp. Med. 1990, 172:955-960.
44. McCauliffe D.P., Lux F.A., Lieu T.S., Sanz I., Hanke J., Newkirk M.M., Bachinski L.L., Itoh Y., Siciliano M.J., Reichlin M., Sontheimer R.D., Capra J.D. Molecular cloning, expression, and chromosome 19 localization of a human Ro/SS-A autoantigen. J. Clin. Invest. 1990, 85:1379-1391.
45. McCauliffe D.P., Yang Y.S., Wilson J., Sontheimer R.D., Capra J.D. The 5'-flanking region of the human calreticulin gene shares homology with the human GRP78, GRP94, and protein disulfide isomerase promoters. J. Biol. Chem. 1992, 267:2557-2562.
46. McHale J.C., McKie A.B., Tarttelin E.E., Inglehearn C.F. Expression map of human chromosome region 17p13.3, spanning the RP13 dominant retinitis pigmentosa locus, the Miller-Dieker lissencephaly syndrome (MDLS) region, and a putative tumour suppressor locus. J. Genome Res. 2000, 88:225-229.
47. Obeid M., Tesniere A., Ghiringhelli F., Fimia G.M., Apetoh L., Perfettini J.-L., Castedo M., Mignot G., Panaretakis T., Casares N., Métivier D., Larochette N., van Endert P., Ciccosanti F., Piacentini M., Zitvogel L., Kroemer G.G. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat. Med. 2006, 13:54-61.
48. Ogden C.A., deCathelineau A., Hoffmann P.R., Bratton D., Ghebrehiwet B., Fadok V.A., Hesnon P.M. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates micropinocytosis and uptake of apoptotic cells. J. Exp. Med. 2001, 194:781-795.
49. Oswald T.J., MacLennan D.H. Isolation of a high affinity calcium binding protein from sarcoplasmic reticulum. J. Biol. Chem. 1974, 249:974-979.
50. Patel J.M., Zhang J., Li Y.D., Block E.R. Calreticulin regulation of lung endothelial NOS activity. Calreticulin 2003, 205-219. Kluwer Academic/Plenum Publishers, New York, NY, USA. 2nd ed. P. Eggleton, M. Michalek (Eds.).
51. Peerschke E.I.B., Malhotra R., Ghebrehiwet B., Reid K.B.M., Willis A.C., Sim R.B. Isolation of a human endothelial cell C1q receptor (C1q-R). J. Leukoc. Biol. 1993, 53:179-184.
52. Peerschke E.I.B., Ghebrehiwet B. The contribution of gC1qR/p33 in Infection and Inflammation. Immunobiology 2007, 212:333-342.
53. Peerschke E.I., Yin W., Ghebrehiwet B. Complement activation on platelets: implications for vascular inflammation and thrombosis. Mol. Immunol. 2010, 47:2170-2175.
54. Reid K.B.M., Thompson R.A. Characterization of non-functional form of C1q found in patients with genetically linked deficiency of C1q activity. Immunology 1983, 20:1117-1125.
55. Reid K.B.M. Molecular cloning and characterization of the complementary DNA and gene coding for the B chain subcomponent C1q of the human complement system. Biochem. J. 1985, 231:729-735.
56. Reid K.B.M. C1q: genes, biosynthesis and biology. Behring Inst. Mitt. 1989, 84:8-19.
57. Rooke K., Briquet-Laugier V., Xia Y.R., Lusis A.J., Doolittle M.H. Mapping of the gene for calreticulin (Calr) to mouse chromosome 8 Mamm. Genome 1997, 8:870-871.
58. Rozanov D.V., Ghebrehiwet B., Postnova T.I., Eichinger A., Deryugina E.I., Srongin A.Y. The hemopexin-like C-terminal domain of membrane type 1 matrix metalloproteinase regulates proteolysis of a multifunctional protein, gC1qR. J. Biol. Chem. 2002, 15:9318-9325.
59. Rubinstein D.B., Stortchevoi A., Boosalis M., Ashfaq R., Ghebrehiwet B., Peerschke E.I.B., Calvo F., Gillaume T. Receptor for the globular heads of C1q (gC1q-R; p33; hyaluronan-binding protein) is preferentially expressed by adenocarcinoma cells. Int. Cancer Res. 2004, 110:741-750.
60. Schumaker V.N., Zavodsky P., Poon P.H. Activation of the first component of complement. Ann. Rev. Immunol. 1987, 5:21-42.
61. Sellar G.C., Blake D.J., Reid K.B.M. Characterization and organization of the genes encoding the A- B-, and C-chains of human complement subcomponent C1q. Biochem. J. 1991, 274:481-490.
62. Shelton E., Yonemasu K., Stroud R.M. Ultrastructure of the human complement component C1q. Proc. Natl. Acad. Sci. U S A 1972, 69:65-68.
63. Singh J.A., Ahmed G., Girardi Role of complement component C1q in the onset of preeclampsia in mice. Hypertension 2011, 58:716-724.
64. Sobel A.T., Bokisch V.A. Receptors for C4b and C1q on human peripheral lymphocytes and lymphoblastoid cells. Membrane Receptors of Lymphocytes 1975, 151-158. Elsevier, New York. M. Seligman, J.I. Preud'home, F.M. Kourilsky (Eds.).
65. Sontheimer R.D., Nguyen T.Q., Cheng S.-T., Lieu T.-S., Capra J.D. The unveiling of calreticulin: a clinically relevant tour of modern cell biology. J. Invest. Med. 1995, 43(362):370.
66. Sontheimer R.D., Racila D., Racila E., Eggleton P., Donnelly S. Calreticulin's role(s) in autoimmune disorders. Calreticulin 2003, 180-192. Eurekah.com and Kluwer Academic/Plenum Publishing, New York, USA. 2nd ed. P. Eggleton, M. Michalak (Eds.).
67. Stuart G.R., Lynch L., Schwaeble W., Sim R. Localization of the C1q and collectin binding site within C1qR. Exp. Clin. Immunogen. 1997, 14:37-40.
68. Svehag S.E., Manheim L., Bloth B. Ultrastructure of human C1q protein. Nat (Lond) New Biol 1972, 238:117-118.
69. Tosato G., Sgadari C., Taga K., Jones K., Pike S., Rosenberg A., Sechler J., Magrath I., Love L., Bhatia K. Regression of experimental Burkitts lymphoma induced by Epstein-Barr virus-immortalized human B-cells. Blood 1994, 83:776-784.
70. Tosato G., Yao L., Pike S.E. Calreticulin and tumor suppression. Calreticulin 2003, 161-179. Eurekah.com and Kluwer Academic/Plenum Publishing, New York, USA. 2nd ed. P. Eggleton, M. Michalak (Eds.).
71. Yin W., Ghebrehiwet B., Weksler B., Peerschke E.I. Regulated complement deposition on the surface of human endothelial cells: effect of tobacco smoke and shear stress. Thromb. Res. 2008, 122:221-228.